Anti-CD37 α-amanitin-conjugated antibodies as potential therapeutic weapons for Richter syndrome

Blood. 2022 Sep 29;140(13):1565-1569. doi: 10.1182/blood.2022016211.

Affiliations

¹ Department of Medical Sciences.
² Department of Molecular Biotechnologies and Health Science, and.
³ Department of Oncology, University of Turin, Turin, Italy.
⁴ Department of Hematology, University Hospital Dubrava, Zagreb, Croatia.
⁵ Department of Clinical and Molecular Medicine, Sapienza University and Sant'Andrea Hospital, Rome, Italy; and.
⁶ Heidelberg Pharma Research GmbH, Heidelberg, Germany.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Alpha-Amanitin* / therapeutic use
Antigens, Neoplasm
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Tetraspanins

Substances

Alpha-Amanitin
Antigens, Neoplasm
Tetraspanins